Chemical industry – Page 53
-
OpinionHow does being a chemist change your view on the world?
Scientific knowledge and analysis shape our view, but can also be selectively ignored
-
BusinessPacBio sues Oxford Nanopore for patent infringement
Firms spar over single-molecule gene sequencing technology
-
WhitepaperAnalytical method transfer
Learn about current best practice in a critical field for the industry
-
BusinessJ&J to close Scottish medical device plant
Up to 400 positions affected as Ethicon subsidiary leaves Livingston
-
BusinessIndustry weighs in on Nafta rewrite
Canadian, Mexican and US trade bodies united in call for more unified regulation in new trade deal
-
BusinessShell shrinks stake in Canadian oil sands
$7.25bn sell-off is part of plan to divest over $30bn in assets to reduce debts
-
BusinessAkzoNobel looks to separate chemicals business
Netherlands-based firm rejects PPG takeover bid, and looks to tighten strategic focus on paints and coatings
-
BusinessExxonMobil to invest $20bn in Gulf Coast manufacturing
Oil giant will fund 11 chemical, refining, lubricant and liquefied natural gas projects from 2013 to at least 2022
-
BusinessAramco and Shell end refining relationship
$2.2 billion divorce deal gives Aramco control of biggest oil refinery in the US
-
BusinessSaudi Aramco to invest $7bn in Malaysian oil refinery
Agreement with Petronas will strengthen Malaysia’s petrochemical megaproject
-
FeatureHow ketamine could help treat severe depression
Nina Notman looks at how the party drug ketamine may hold the key to treating patients with severe depression
-
BusinessCristal deal will make Tronox world’s largest titanium dioxide producer
Tronox to sell alkali business to fund $1.67bn transaction
-
OpinionOutlines of ignorance
There’s a lot about chemistry that we just don’t understand very well yet
-
OpinionCollaboration and competition can both stimulate innovation
Diverse approaches suit different goals
-
BusinessCrispr patent ruling breaks deadlock
Both sides claim victory as board rules patents do not interfere with each other
-
Business$2bn Immunomedics–Seattle Genetics deal delayed amid shareholder infighting
Major investor venBio seeks to derail deal and replace board members
-
ArticleIncreasing lab efficiencies through bespoke solutions
More custom products, more tailored packaging, more productivity
-
FeatureDeal or no deal?
Clare Sansom highlights recent changes in the landscape of pharma company collaborations and acquisitions
-
BusinessUniversity–industry collaborations aspire to pharmaceutical innovation
Three new UK partnerships illustrate drug research co-operation approaches that are growing in popularity
-
BusinessReckitt Benckiser to buy into baby milk
$17bn acquisition of Mead Johnson expands presence in developing markets, especially China